Next report date
Report period
Q1 2024
EPS estimate
−0.34USD
Revenue estimate
—
−1.52USD
−235.93 MUSD
53.21 M
About Neumora Therapeutics, Inc.
Sector
CEO
Henry O. Gosebruch
Headquarters
Watertown
Website
Employees (FY)
124
Founded
2019
FIGI
BBG012W9C4X1
Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. The firm focuses on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action with best-in-class pharmacology. The company was founded by Paul L. Berns, Carol Suh and Mike Poole in November 2019 and is headquartered in Watertown, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NMRA is 9.25 USD — it has increased by 0.33% in the past 24 hours. Watch Neumora Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Neumora Therapeutics, Inc. stocks are traded under the ticker NMRA.
Neumora Therapeutics, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
NMRA stock is 4.89% volatile and has beta coefficient of 1.35. Track Neumora Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Neumora Therapeutics, Inc. there?
NMRA earnings for the last quarter are −1.14 USD per share, whereas the estimation was −0.35 USD resulting in a −228.40% surprise. The estimated earnings for the next quarter are −0.55 USD per share. See more details about Neumora Therapeutics, Inc. earnings.
Yes, you can track Neumora Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
NMRA stock has risen by 3.47% compared to the previous week, the month change is a 32.23% fall, over the last year Neumora Therapeutics, Inc. has showed a 43.94% decrease.
NMRA net income for the last quarter is −108.73 M USD, while the quarter before that showed −53.03 M USD of net income which accounts for −105.05% change. Track more Neumora Therapeutics, Inc. financial stats to get the full picture.
Today Neumora Therapeutics, Inc. has the market capitalization of 1.47 B, it has decreased by 9.10% over the last week.
No, NMRA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NMRA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Neumora Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
NMRA reached its all-time high on Mar 8, 2024 with the price of 21.00 USD, and its all-time low was 8.82 USD and was reached on Apr 26, 2024. View more price dynamics on NMRA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
As of May 5, 2024, the company has 124.00 employees. See our rating of the largest employees — is Neumora Therapeutics, Inc. on this list?
We've gathered analysts' opinions on Neumora Therapeutics, Inc. future price: according to them, NMRA price has a max estimate of 29.00 USD and a min estimate of 22.00 USD. Watch NMRA chart and read a more detailed Neumora Therapeutics, Inc. stock forecast: see what analysts think of Neumora Therapeutics, Inc. and suggest that you do with its stocks.